The Misinformation Maze: Navigating Public Health in the Digital Age
Jennifer Butler, chief commercial officer of Pleio, discusses misinformation's threat to public health, where patients are turning for trustworthy health information, the industry's pivot to peer-to-patient strategies to educate patients, and more.
In this episode of the Pharmaceutical Executive podcast, Jennifer Butler, chief commercial officer of Pleio, discusses:
- The threat of misinformation to public health and how emotional appeal plays a part.
- Where patients are turning for trustworthy health information.
- Strategies that can be used to verify information.
- Pharma's role in helping to ensure patients have access to health insights they can trust.
- Why the industry is turning to peer-to-patient platforms, trusted patient communities, and pharmacies to educate patients.
- What kind of role regulatory agencies should play in the battle against misinformation.
- and more!
Jennifer Butler, chief commercial officer of Pleio, discusses misinformation's threat to public health, where patients are turning for trustworthy health information, the industry's pivot to peet-to-patient strategies to educate patients, and more.
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
